[Comparative study of the efficacy and safety of Ranquilon and Afobazol in the treatment of patients with anxiety associated with neurasthenia and adjustment di
To evaluate the efficacy and safety of Ranquilon1 at 6 mg daily, compared with Afobazol (fabomotizole) at 30 mg daily, for the treatment of patients with anxiety associated with neurasthenia and adjustment disorders. The clinical study included 200 patients diagnosed with anxiety
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.